• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测新型冠状病毒肺炎的疾病严重程度和短期预后:一项在中国进行的回顾性队列研究。

Predicting Illness Severity and Short-Term Outcomes of COVID-19: A Retrospective Cohort Study in China.

作者信息

Chen Chuming, Wang Haihui, Liang Zhichao, Peng Ling, Zhao Fang, Yang Liuqing, Cao Mengli, Wu Weibo, Jiang Xiao, Zhang Peiyan, Li Yinfeng, Chen Li, Feng Shiyan, Li Jianming, Meng Lingxiang, Wu Huishan, Wang Fuxiang, Liu Quanying, Liu Yingxia

机构信息

Department of Infectious Diseases, Shenzhen Key Laboratory of Pathogen and Immunity, State Key Discipline of Infectious Disease, The Third People's Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, Guangdong 518000, China.

Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, Guangdong 518000, China.

出版信息

Innovation (Camb). 2020 May 21;1(1):100007. doi: 10.1016/j.xinn.2020.04.007. Epub 2020 May 20.

DOI:10.1016/j.xinn.2020.04.007
PMID:33554186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7237911/
Abstract

Among 417 COVID-19 patients in Shenzhen, demographic characteristics, clinical manifestations and baseline laboratory tests showed significant differences between mild-moderate cohort and severe-critical cohort.Based on these differences, a convenient mathematical model was established to predict the illness severity of COVID-19. The model includes four parameters: age, BMI, CD4 lymphocytes and IL-6 levels. The AUC of the model is 0.911.The high risk factors for developing to severe COVID-19 are: age ≥ 55 years, BMI > 27 kg / m, IL-6 ≥ 20 pg / ml, CD4 T cell ≤ 400 count / μ L.Among 249 discharged COVID-19 patients, those who recovered after 20 days had a lower count of platelet, a higher level of estimated glomerular filtration rate, and higher level of interleukin-6 and myoglobin than those who recovered within 20 days.

摘要

在深圳的417例新冠肺炎患者中,轻 - 中度组和重度 - 危重组在人口统计学特征、临床表现和基线实验室检查方面存在显著差异。基于这些差异,建立了一个便捷的数学模型来预测新冠肺炎的疾病严重程度。该模型包括四个参数:年龄、体重指数(BMI)、CD4淋巴细胞和白细胞介素 - 6(IL - 6)水平。该模型的曲线下面积(AUC)为0.911。发展为重症新冠肺炎的高危因素为:年龄≥55岁、BMI>27kg/m²、IL - 6≥20pg/ml、CD4 T细胞≤400个/μL。在249例出院的新冠肺炎患者中,20天后康复的患者血小板计数较低,估算肾小球滤过率水平较高,白细胞介素 - 6和肌红蛋白水平高于20天内康复的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/528a/8454621/b97a4d53f064/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/528a/8454621/14d35730ace4/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/528a/8454621/32a71cbb5728/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/528a/8454621/b97a4d53f064/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/528a/8454621/14d35730ace4/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/528a/8454621/32a71cbb5728/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/528a/8454621/b97a4d53f064/gr2.jpg

相似文献

1
Predicting Illness Severity and Short-Term Outcomes of COVID-19: A Retrospective Cohort Study in China.预测新型冠状病毒肺炎的疾病严重程度和短期预后:一项在中国进行的回顾性队列研究。
Innovation (Camb). 2020 May 21;1(1):100007. doi: 10.1016/j.xinn.2020.04.007. Epub 2020 May 20.
2
The dynamics of immune response in COVID-19 patients with different illness severity.不同疾病严重程度的 COVID-19 患者的免疫反应动力学。
J Med Virol. 2021 Feb;93(2):1070-1077. doi: 10.1002/jmv.26504. Epub 2020 Oct 10.
3
The clinical course and its correlated immune status in COVID-19 pneumonia.新型冠状病毒肺炎的临床过程及其相关免疫状态。
J Clin Virol. 2020 Jun;127:104361. doi: 10.1016/j.jcv.2020.104361. Epub 2020 Apr 12.
4
Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes.2 型糖尿病重症 COVID-19 患者的危险因素临床分析。
J Diabetes Complications. 2020 Oct;34(10):107666. doi: 10.1016/j.jdiacomp.2020.107666. Epub 2020 Jun 29.
5
Development of a clinical decision support system for severity risk prediction and triage of COVID-19 patients at hospital admission: an international multicentre study.开发一种临床决策支持系统,用于预测 COVID-19 患者入院时的严重程度风险和分诊:一项国际多中心研究。
Eur Respir J. 2020 Aug 20;56(2). doi: 10.1183/13993003.01104-2020. Print 2020 Aug.
6
Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study.适应性免疫功能障碍与 COVID-19 严重程度相关:一项回顾性研究。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620942129. doi: 10.1177/1753466620942129.
7
Decreased T cell populations contribute to the increased severity of COVID-19.T 细胞群体减少导致 COVID-19 病情加重。
Clin Chim Acta. 2020 Sep;508:110-114. doi: 10.1016/j.cca.2020.05.019. Epub 2020 May 13.
8
Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.基于细胞因子和淋巴细胞亚群组合的 SARS-CoV-2 感染预后预测模型。
J Clin Immunol. 2020 Oct;40(7):960-969. doi: 10.1007/s10875-020-00821-7. Epub 2020 Jul 13.
9
Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)住院儿科患者的临床和免疫特征。
JAMA Netw Open. 2020 Jun 1;3(6):e2010895. doi: 10.1001/jamanetworkopen.2020.10895.
10
Development and validation of a prognostic nomogram for predicting in-hospital mortality of COVID-19: a multicenter retrospective cohort study of 4086 cases in China.开发和验证一种预测 COVID-19 住院患者死亡率的预后列线图:一项中国多中心回顾性队列研究 4086 例。
Aging (Albany NY). 2021 Feb 9;13(3):3176-3189. doi: 10.18632/aging.202605.

引用本文的文献

1
Machine learning-based prediction of the risk of moderate-to-severe catheter-related bladder discomfort in general anaesthesia patients: a prospective cohort study.基于机器学习的全麻患者中中重度导管相关膀胱不适风险预测:一项前瞻性队列研究。
BMC Anesthesiol. 2024 Sep 19;24(1):334. doi: 10.1186/s12871-024-02720-5.
2
A multimodal integration pipeline for accurate diagnosis, pathogen identification, and prognosis prediction of pulmonary infections.一种用于肺部感染的准确诊断、病原体鉴定和预后预测的多模态整合流程。
Innovation (Camb). 2024 May 22;5(4):100648. doi: 10.1016/j.xinn.2024.100648. eCollection 2024 Jul 1.
3

本文引用的文献

1
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.5 例危重症 COVID-19 患者接受恢复期血浆治疗。
JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.
2
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
3
Potential association between COVID-19 mortality and health-care resource availability.
Abnormal myocardial enzymes in the prediction of mortality and hypertension in COVID-19 patients: a retrospective study.
COVID-19 患者心肌酶谱异常与死亡率和高血压的相关性:一项回顾性研究。
Aging (Albany NY). 2022 Nov 2;14(21):8585-8594. doi: 10.18632/aging.204362.
4
Clinical Characteristics, Risk Factors for Severity and Pharmacotherapy in Hospitalized COVID-19 Patients in the United Arab Emirates.阿拉伯联合酋长国住院COVID-19患者的临床特征、严重程度危险因素及药物治疗
J Clin Med. 2022 Apr 26;11(9):2439. doi: 10.3390/jcm11092439.
5
Infection Analysis (iSFA) Identified Coronavirus Infection and Potential Transmission Risk in Mammals.感染分析(iSFA)确定了哺乳动物中的冠状病毒感染及潜在传播风险。
Front Mol Biosci. 2022 Feb 8;9:831876. doi: 10.3389/fmolb.2022.831876. eCollection 2022.
6
Accelerating drug repurposing for COVID-19 treatment by modeling mechanisms of action using cell image features and machine learning.通过利用细胞图像特征和机器学习对作用机制进行建模,加速用于治疗新冠肺炎的药物重新利用。
Cogn Neurodyn. 2023 Jun;17(3):803-811. doi: 10.1007/s11571-021-09727-5. Epub 2021 Nov 5.
7
Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach.采用定量蛋白质组学方法鉴定严重 COVID-19 的血清预后生物标志物。
Sci Rep. 2021 Oct 19;11(1):20638. doi: 10.1038/s41598-021-98253-9.
8
Lipid profile as an indicator of COVID-19 severity: A systematic review and meta-analysis.脂质谱作为 COVID-19 严重程度的指标:系统评价和荟萃分析。
Clin Nutr ESPEN. 2021 Oct;45:91-101. doi: 10.1016/j.clnesp.2021.07.023. Epub 2021 Jul 31.
9
Addressing the 'hypoxia paradox' in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues.解决重症 COVID-19 中的“缺氧悖论”:文献回顾和四例接受促红细胞生成素类似物治疗的病例报告。
Mol Med. 2021 Sep 26;27(1):120. doi: 10.1186/s10020-021-00381-5.
10
The role of meningeal populations of type II innate lymphoid cells in modulating neuroinflammation in neurodegenerative diseases.II 型固有淋巴细胞脑膜细胞群体在调节神经退行性疾病神经炎症中的作用。
Exp Mol Med. 2021 Sep;53(9):1251-1267. doi: 10.1038/s12276-021-00660-5. Epub 2021 Sep 6.
新型冠状病毒肺炎死亡率与医疗资源可及性之间的潜在关联。
Lancet Glob Health. 2020 Apr;8(4):e480. doi: 10.1016/S2214-109X(20)30068-1. Epub 2020 Feb 25.
4
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
5
An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov).新型冠状病毒(2019-nCov)传播风险的最新评估。
Infect Dis Model. 2020 Feb 11;5:248-255. doi: 10.1016/j.idm.2020.02.001. eCollection 2020.
6
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.从 2019 年新冠病毒感染患者中提取的临床和生化指标与病毒载量和肺部损伤有关。
Sci China Life Sci. 2020 Mar;63(3):364-374. doi: 10.1007/s11427-020-1643-8. Epub 2020 Feb 9.
7
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
8
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.实时预测和预报源自中国武汉的 2019-nCoV 疫情在国内和国际的潜在传播:一项建模研究。
Lancet. 2020 Feb 29;395(10225):689-697. doi: 10.1016/S0140-6736(20)30260-9. Epub 2020 Jan 31.
9
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
10
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.新型冠状病毒感染肺炎在中国武汉的早期传播动力学。
N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.